Figure 4From: Clinical implications of novel activating EGFR mutations in malignant peritoneal mesotheliomaEGFR mutations from MPM tumor samples are activating mutations. Western blot analysis of phosphorylated EGFR and total EGFR from transfectants expressing EGFR mutations.Back to article page